Fiasp® and NovoLog® share the same generic name, so it is important to specify the Fiasp® brand name on your script to avoid any confusion at the pharmacy.
NovoLog®—an insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus

Fiasp® gives patients with diabetes dose timing flexibility2
Instruct patients on basal-bolus treatment who forget a mealtime dose to monitor their blood glucose level to decide if an insulin dose is needed, and to resume their usual dosing schedule at the next meal.
Fast Facts to remember about Fiasp®

Converting patients from another mealtime insulin can be done on a unit-to-unit basis2

Dosage should be based on each patient’s unique metabolic needs and glycemic results and goal2

Fiasp® provides 4 delivery options: Fiasp® FlexTouch® pen, PenFill® cartridge, PumpCart® cartridge, and a vial
